Celltrion Buys Asia-Pacific Business of 18 Takeda Pharma Brands

SEOUL, June 11 (Korea Bizwire) — Celltrion Inc., a South Korean biopharmaceutical firm, announced Thursday that it has signed an agreement to acquire the business rights for 18 brands of Takeda Pharmaceutical of Japan in the Asia-Pacific region. Under the 332.4 billion won (US$278.2 million) deal, Celltrion is set to secure the patent, trademark and [...]